Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Morepen Laboratories Ltd. has got clearance from Subject Expert Committee of CDSCO to conduct Bioequivalence studies for ...

Morepen Laboratories gains CDSCO approval for Resmetirom bioequivalence studies, positioning the company for global NASH ...

The pharmaceutical company received clearance from the Subject Expert Committee (SEC) of CDSCO to conduct bioequivalence (‘BE ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

but US biotech Madrigal Pharma thinks it now has enough evidence for its drug resmetirom to support regulatory filings. The Massachusetts company has reported the results of the phase 3 MAESTRO ...

Gurugram: Morepen Laboratories Ltd. has received clearance from the Subject Expert Committee (SEC) of Central Drugs Standard ...

"Patients with compensated MASH cirrhosis who develop clinically significant portal hypertension are at greatly elevated risk of experiencing life-threatening complications of late-stage liver disease ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...